Preparation of novel substituted haloarene compounds

Details for Australian Patent Application No. 2005266070 (hide)

Owner Pfizer Products Inc.

Inventors Hawkins, Joel Michael; Rutherford, Jennifer Lea

Agent Spruson & Ferguson

Pub. Number AU-A-2005266070

PCT Pub. Number WO2006/011030

Priority 60/589,152 19.07.04 US

Filing date 7 July 2005

Wipo publication date 2 February 2006

International Classifications

C07D 213/61 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07C 2/00 (2006.01) Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms

C07C 25/02 (2006.01) Compounds containing at least one halogen atom bound to a six-membered aromatic ring

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/011030 Priority application(s): WO2006/011030

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266080-Quinazolin-4-YLpiperidine and cinnolin-4-YLpiperidine derivatives as PDE10 inhibitors for the treatment of CNS disorders

2005266065-System and method for providing UPnP announcements convergence